AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $24.33M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.00pm 06/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 6.7¢ | Day High | 6.7¢ | Day Low | 6.6¢ | |||
| Daily Volume | 124525 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 6.5¢ | 20000 | 0 | 7.0¢ | 20000 | |
Directors & Senior Management
| Alexandra Feetham | Head of Innovation |
| Ms. Anne-Louise Arnett | Chief Executive Officer |
| Dr. David Gregory Darling | Non-Executive Director |
| Mr. Guy Adrian Robertson | CFO & Company Secretary |
| Ms. Jayne Andrea Shaw | Co-Founder & Executive Chairman |
| Dr. John G. Hurrell | Independent Non-Executive Director & Consultant |
| Mr. Jonathan Alfred Grey Trollip | Independent Non-Executive Director |
| Mr. Mark Steven McConnell | Non-Executive Director |
| Mr. Sean Alexander Kennedy | Director of Corporate Finance |
Data source: ADVFN
